Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2025 Filed Feb 27, 2025 21:18 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 44,959 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-25-000054 · wk-form4_1740691096.xml · nonDerivative · entry 2 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,276 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2022-2024 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:18 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 17,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-25-000054 · wk-form4_1740691096.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,317 F1 · price: Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-25-000036 · wk-form4_1736199709.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,749 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC |
Herzog David LDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000035 · wk-form4_1736199698.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,875 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000034 · wk-form4_1736199688.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,058 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-25-000033 · wk-form4_1736199678.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,805 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000032 · wk-form4_1736199666.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,558 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000031 · wk-form4_1736199654.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,076 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-25-000030 · wk-form4_1736199644.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,715 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 918 | $81.78 | $75,074.04 |
DisclosureSEC source: 0001099219-25-000029 · wk-form4_1736199632.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,328 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000028 · wk-form4_1736199621.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,604 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000027 · wk-form4_1736199610.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,336 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000026 · wk-form4_1736199599.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,667 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:39 UTC |
Kennard William EDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000025 · wk-form4_1736199589.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,907 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:34 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 33 | $82.74 | $2,730.42 |
DisclosureSEC source: 0001099219-24-000288 · wk-form4_1734557635.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,069 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC |
Herzog David LDirector
|
GrantCommon Stock | 39 | $82.74 | $3,226.86 |
DisclosureSEC source: 0001099219-24-000287 · wk-form4_1734557625.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,340 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC |
Kennard William EDirector
|
GrantCommon Stock | 271 | $82.74 | $22,422.54 |
DisclosureSEC source: 0001099219-24-000286 · wk-form4_1734557614.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,372 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 13 | $82.74 | $1,075.62 |
DisclosureSEC source: 0001099219-24-000285 · wk-form4_1734557605.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,023 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 132 | $82.74 | $10,921.68 |
DisclosureSEC source: 0001099219-24-000284 · wk-form4_1734557595.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,132 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 536 | $82.74 | $44,348.64 |
DisclosureSEC source: 0001099219-24-000283 · wk-form4_1734557584.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,541 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:32 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 232 | $82.74 | $19,195.68 |
DisclosureSEC source: 0001099219-24-000281 · wk-form4_1734557564.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,523 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 579 | $82.74 | $47,906.46 |
DisclosureSEC source: 0001099219-24-000282 · wk-form4_1734557574.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,410 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:32 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 16 | $82.74 | $1,323.84 |
DisclosureSEC source: 0001099219-24-000280 · wk-form4_1734557553.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,801 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 9,703 | $0.00 Strike: $45.91 | $0.00 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · derivative · entry 5 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,703 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 13,107 | $0.00 Strike: $34.33 | $0.00 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,107 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
SaleCommon Stock | 22,810 | $82.88 | $1,890,577.20 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,507 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionCommon Stock | 9,703 | $45.91 | $445,464.73 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionCommon Stock | 13,107 | $34.33 | $449,963.31 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 26,138 | $0.00 Strike: $45.91 | $0.00 |
DisclosureSEC source: 0001099219-24-000269 · wk-form4_1734470415.xml · derivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,138 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 2,787 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
Khalaf MichelDirector · President & CEO
|
SaleCommon Stock | 20,926 | $82.84 | $1,733,604.01 |
DisclosureSEC source: 0001099219-24-000269 · wk-form4_1734470415.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,799 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 13, 2024, and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.82 to $82.95, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionCommon Stock | 26,138 | $45.91 | $1,199,995.58 |
DisclosureSEC source: 0001099219-24-000269 · wk-form4_1734470415.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:17 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000253 · wk-form4_1727986659.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,291 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:17 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000252 · wk-form4_1727986648.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,036 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:17 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000251 · wk-form4_1727986638.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,785 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:17 UTC |
Kennard William EDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000250 · wk-form4_1727986627.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,102 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:17 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000249 · wk-form4_1727986616.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,270 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000248 · wk-form4_1727986605.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,006 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
Herzog David LDirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000247 · wk-form4_1727986593.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,300 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000246 · wk-form4_1727986582.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,180 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000245 · wk-form4_1727986571.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,010 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000244 · wk-form4_1727986558.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,214 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:15 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000243 · wk-form4_1727986546.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:15 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 918 | $81.78 | $75,074.04 |
DisclosureSEC source: 0001099219-24-000242 · wk-form4_1727986536.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,831 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:33 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 586 | $74.63 | $43,733.18 |
DisclosureSEC source: 0001099219-24-000229 · wk-form4_1726173206.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,471 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:33 UTC |
Kennard William EDirector
|
GrantCommon Stock | 294 | $74.63 | $21,941.22 |
DisclosureSEC source: 0001099219-24-000228 · wk-form4_1726173194.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,567 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:33 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 252 | $74.63 | $18,806.76 |
DisclosureSEC source: 0001099219-24-000227 · wk-form4_1726173182.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,756 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:32 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 14 | $74.63 | $1,044.82 |
DisclosureSEC source: 0001099219-24-000226 · wk-form4_1726173169.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:32 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 631 | $74.63 | $47,091.53 |
DisclosureSEC source: 0001099219-24-000225 · wk-form4_1726173157.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,913 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:32 UTC |
Herzog David LDirector
|
GrantCommon Stock | 43 | $74.63 | $3,209.09 |
DisclosureSEC source: 0001099219-24-000224 · wk-form4_1726173146.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,765 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:32 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 141 | $74.63 | $10,522.83 |
DisclosureSEC source: 0001099219-24-000223 · wk-form4_1726173134.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,465 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.